Cerebral glucose metabolism in adults with neurofibromatosis type 1

Brain Research
Ivayla ApostolovaRalph Buchert

Abstract

Previous studies with positron emission tomography (PET) and the glucose analog F-18-fluorodeoxyglucose (FDG) in patients with neurofibromatosis type 1 (NF1) suggest reduced cerebral glucose metabolism in NF1 specifically in the thalamus. The latter is distinguished by extensive neural circuitry connections which makes thalamic hypoactivity in NF1 an interesting finding. Yet it is not very well confirmed, since previous studies were limited by small sample size and/or poorly matched control groups. Primary aim of the present study therefore was to compare brain FDG PET between a large sample of NF1 patients and a well-matched control group. Secondary aim was to test for an NF1-associated FDG effect in the amygdala, as increased blood flow in the amygdala has recently been detected in a mouse model of NF1. Fifty adult NF1 patients and 50 gender- and age-matched control subjects were included retrospectively. Voxel-wise comparison of brain FDG uptake was performed using the statistical parametric mapping (SPM8). Additional region-of-interest (ROI) analysis was performed using standard ROI templates. Voxel-based testing revealed a single 11.2 ml cluster of reduced FDG uptake in the thalamus of NF1 patients. There was no further si...Continue Reading

References

Dec 1, 1994·Journal of Neurology, Neurosurgery, and Psychiatry·P BalestriF Fazio
Jan 16, 1998·Journal of Child Neurology·A M KaplanE M Reiman
Oct 31, 2002·Journal of Child Neurology·Kathryn NorthBelinda Barton
Jan 14, 2003·Trends in Molecular Medicine·Rui M Costa, Alcino J Silva
Dec 1, 2007·Nuclear Medicine Communications·Ralph BuchertVictor F Mautner
Feb 4, 2010·The American Journal of Psychiatry·Iliyan IvanovBradley S Peterson
Feb 27, 2010·Journal of Neurology, Neurosurgery, and Psychiatry·Jonathan M PayneKathryn N North
Sep 14, 2012·NeuroImage·Ivayla ApostolovaRalph Buchert
Oct 12, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David H GutmannNancy Ratner
Oct 26, 2012·Journal of Intellectual Disability Research : JIDR·M-J DescheemaekerE Legius
Feb 8, 2014·Neuropediatrics·Karen LidzbaVictor-Felix Mautner
Sep 23, 2014·Nature Neuroscience·Andrei I MoloshAnantha Shekhar
Mar 10, 2015·Applied Neuropsychology. Child·Teresa Bailey, Arthur Joyce
Mar 19, 2015·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Ivayla ApostolovaRalph Buchert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Related Papers

Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
Ivayla ApostolovaRalph Buchert
Journal of the Neurological Sciences
Takashi KawachiMasahiro Sasaki
Revista española de medicina nuclear
Grupo PET de la SEMN.
© 2021 Meta ULC. All rights reserved